一个疾病模型资源揭示了组织特异性癌症演变的核心原则
Sebastian Mueller1,2, Niklas de Andrade Krätzig1,2, Markus Tschurtschenthaler2,3,4,5
1Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, TU Munich, Munich, Germany.
Nature
|February 25, 2026
概括
了解KRAS瘤基因是如何驱动癌症的,因组织而异. 这项研究揭示了组织特异性癌症演变的关键原则,使用了一种新的小鼠模型地图.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 像KRAS这样的瘤基因在癌症发病和进展方面显示出显著的组织特异性影响.
- 驱动这种组织特异性的分子决定因素在很大程度上仍然未知.
- 了解这些差异对于开发向癌症疗法至关重要.
研究的目的:
- 研究KRAS引发的癌症的组织特异性演变的核心原则.
- 确定决定KRAS在不同组织中的瘤潜在的遗传和细胞因素.
- 为研究KRAS驱动的癌症建立一个全面的资源.
主要方法:
- 开发和利用老鼠癌细胞谱图 (MCCA) 的开发和利用,590个特征模型的资源.
- 综合MCCA数据与人类队列和小鼠模型进行的比较和功能研究.
- 对突变KRAS剂量,协作变化和瘤抑制剂相互作用的分析.
主要成果:
- 突变KRAS剂量增加具有细胞类型特异性影响,影响癌症发病时间 (例如胰腺癌).
- 组织和阶段特定的要求 (例如,阻断肠道的分化) 选择KRAS合作的变化.
- KRAS和瘤抑制剂之间的上下文依赖的相互作用,以及相互的剂量敏感性,决定了实体特定的癌症基因改变模式.
结论:
- 内在和获得的因素在各个组织中不同地指导癌症的演变,从而导致可预测的分子和表型结果.
- 这项研究促进了对癌症基因组的机制学理解,以及癌症驱动因素的组织特异性.
- 该MCCA资源为未来研究癌症异质性和有针对性的治疗策略提供了一个平台.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
02:43Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
02:40Cancer Stem Cells and Tumor Maintenance
6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K
02:12What is Cancer?
14.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.8K